NEUROLOGY 2007;68:116-121
© 2007 American Academy of Neurology
The increasing incidence of anticoagulant-associated intracerebral hemorrhage
M. L. Flaherty, MD,
B. Kissela, MD,
D. Woo, MD,
D. Kleindorfer, MD,
K. Alwell, BSN,
P. Sekar, MS,
C. J. Moomaw, PhD,
M. Haverbusch, BSN and
J. P. Broderick, MD
From the Departments of Neurology (M.L.F., B.K., D.W., D.K., K.A., C.J.M., M.H., J.P.B.) and Environmental Health (P.S.), University of Cincinnati College of Medicine, OH.
Address correspondence and reprint requests to Dr. Matthew L. Flaherty, 231 Albert Sabin Way, MSB Room 5060, University of Cincinnati Medical Center, Cincinnati, OH 45267-0525; e-mail: matthew.flaherty{at}uc.edu
Objective: To define temporal trends in the incidence of anticoagulant-associated intracerebral hemorrhage (AAICH) during the 1990s and relate them to rates of cardioembolic ischemic stroke.
Methods: We identified all patients hospitalized with first-ever intracerebral hemorrhage (ICH) in greater Cincinnati during 1988, from July 1993 through June 1994, and during 1999. AAICH was defined as ICH in patients receiving warfarin or heparin. Patients from the same region hospitalized with first-ever ischemic stroke of cardioembolic mechanism were identified during 1993/1994 and 1999. Incidence rates were calculated and adjusted to the 2000 US population. Estimates of warfarin distribution in the United States were obtained for the years 1988 through 2004.
Results: AAICH occurred in 9 of 184 ICH cases (5%) in 1988, 23 of 267 cases (9%) in 1993/1994, and 54 of 311 cases (17%) in 1999 (p < 0.001). The annual incidence of AAICH per 100,000 persons was 0.8 (95% CI 0.3 to 1.3) in 1988, 1.9 (1.1 to 2.7) in 1993/1994, and 4.4 (3.2 to 5.5) in 1999 (p < 0.001 for trend). Among persons aged  80, the AAICH rate increased from 2.5 (0 to 7.4) in 1988 to 45.9 (25.6 to 66.2) in 1999 (p < 0.001 for trend). Incidence rates of cardioembolic ischemic stroke were similar in 1993/1994 and 1999 (31.1 vs 30.4, p = 0.65). Warfarin distribution in the United States quadrupled on a per-capita basis between 1988 and 1999.
Conclusions: The incidence of anticoagulant-associated intracerebral hemorrhage quintupled in our population during the 1990s. The majority of this change can be explained by increasing warfarin use. Anticoagulant-associated intracerebral hemorrhage now occurs at a frequency comparable to subarachnoid hemorrhage.
Supported in part by National Institute of Neurological Disorders and Stroke (R-01-NS 030678).
Disclosure: The authors report no conflicts of interest.
Received June 12, 2006. Accepted in final form September 28, 2006.
Related Article
-
January 9 Highlights
Neurology 2007 68: 86-87.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
T. Steiner and J. Bosel
Options to Restrict Hematoma Expansion After Spontaneous Intracerebral Hemorrhage
Stroke,
February 1, 2010;
41(2):
402 - 409.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. P. Moyer, D. J. O'Kane, L. M. Baudhuin, C. L. Wiley, A. Fortini, P. K. Fisher, D. M. Dupras, R. Chaudhry, P. Thapa, A. R. Zinsmeister, et al.
Warfarin Sensitivity Genotyping: A Review of the Literature and Summary of Patient Experience
Mayo Clin. Proc.,
December 1, 2009;
84(12):
1079 - 1094.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. W. Vernooij, M. D. M. Haag, A. van der Lugt, A. Hofman, G. P. Krestin, B. H. Stricker, and M. M. B. Breteler
Use of Antithrombotic Drugs and the Presence of Cerebral Microbleeds: The Rotterdam Scan Study
Arch Neurol,
June 1, 2009;
66(6):
714 - 720.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. L. Flaherty, O. Adeoye, P. Sekar, M. Haverbusch, C. J. Moomaw, H. Tao, J. P. Broderick, and D. Woo
The Challenge of Designing a Treatment Trial for Warfarin-Associated Intracerebral Hemorrhage
Stroke,
May 1, 2009;
40(5):
1738 - 1742.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. S. Mullins, K. W. Kombrinck, K. E. Talmage, M. A. Shaw, D. P. Witte, J. M. Ullman, S. J. Degen, W. Sun, M. J. Flick, and J. L. Degen
Genetic elimination of prothrombin in adult mice is not compatible with survival and results in spontaneous hemorrhagic events in both heart and brain
Blood,
January 15, 2009;
113(3):
696 - 704.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-H. Lee, W.-S. Ryu, and J.-K. Roh
Cerebral microbleeds are a risk factor for warfarin-related intracerebral hemorrhage
Neurology,
January 13, 2009;
72(2):
171 - 176.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Foerch, K. Arai, G. Jin, K.-P. Park, S. Pallast, K. van Leyen, and E. H. Lo
Experimental Model of Warfarin-Associated Intracerebral Hemorrhage
Stroke,
December 1, 2008;
39(12):
3397 - 3404.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. H. Eckman, L. K.S. Wong, Y. O.Y. Soo, W. Lam, S. R. Yang, S. M. Greenberg, and J. Rosand
Patient-Specific Decision-Making for Warfarin Therapy in Nonvalvular Atrial Fibrillation: How Will Screening With Genetics and Imaging Help? * Supplemental Appendix
Stroke,
December 1, 2008;
39(12):
3308 - 3315.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. O. Claassen, N. Kazemi, A. Y. Zubkov, E. F. M. Wijdicks, and A. A. Rabinstein
Restarting Anticoagulation Therapy After Warfarin-Associated Intracerebral Hemorrhage
Arch Neurol,
October 1, 2008;
65(10):
1313 - 1318.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Y. Zubkov, J. N. Mandrekar, D. O. Claassen, E. M. Manno, E. F. M. Wijdicks, and A. A. Rabinstein
Predictors of Outcome in Warfarin-Related Intracerebral Hemorrhage
Arch Neurol,
October 1, 2008;
65(10):
1320 - 1325.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. L. Flaherty, H. Tao, M. Haverbusch, P. Sekar, D. Kleindorfer, B. Kissela, P. Khatri, B. Stettler, O. Adeoye, C. J. Moomaw, et al.
Warfarin use leads to larger intracerebral hematomas
Neurology,
September 30, 2008;
71(14):
1084 - 1089.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. S. Rost, E. E. Smith, Y. Chang, R. W. Snider, R. Chanderraj, K. Schwab, E. FitzMaurice, L. Wendell, J. N. Goldstein, S. M. Greenberg, et al.
Prediction of Functional Outcome in Patients With Primary Intracerebral Hemorrhage: The FUNC Score
Stroke,
August 1, 2008;
39(8):
2304 - 2309.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. S. Rost, S. M. Greenberg, and J. Rosand
The Genetic Architecture of Intracerebral Hemorrhage
Stroke,
July 1, 2008;
39(7):
2166 - 2173.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. L Garwood and T. L Corbett
Use of Anticoagulation in Elderly Patients with Atrial Fibrillation Who Are at Risk for Falls
Ann. Pharmacother.,
April 1, 2008;
42(4):
523 - 532.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. B. Goldstein and P. M. Rothwell
Advances in Prevention and Health Services Delivery 2007
Stroke,
February 1, 2008;
39(2):
258 - 260.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. H. Falk
Ethnic Disparity in Intracranial Hemorrhage Among Anticoagulated Patients With Atrial Fibrillation: An Answer in Search of a Question?
J. Am. Coll. Cardiol.,
July 24, 2007;
50(4):
316 - 318.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Warfarin-Associated Intracerebral Hemorrhage
Journal Watch Cardiology,
February 21, 2007;
2007(221):
4 - 4.
[Full Text]
|
|
|
|
|
|
|
Anticoagulant-Associated Intracerebral Hemorrhage
Journal Watch Neurology,
February 20, 2007;
2007(220):
1 - 1.
[Full Text]
|
|
|
|
|
|
|
Intracerebral Hemorrhage Associated with Warfarin
Journal Watch (General),
January 23, 2007;
2007(123):
2 - 2.
[Full Text]
|
|
|
|
